Murray Includes $1.25 Million for Cutting-Edge Cancer Research in Kennewick Funding will allow company to continue developing promising new cancer treatment
For Immediate Release: Thursday, October 15, 2009
WASHINGTON, D.C.) – Today, U.S. Senator Patty Murray (D-WA) announced that that the the $1.25 million she included for cancer research at Advanced Medical Isotope Corporation in the fiscal year 2010 Senate Energy and Water Development appropriations bill has been included in the final version of the spending bill. The bill has now been approved by both houses of Congress after passing the Senate today by a vote of 80-17 and will now head to the President who is expected to sign it into law. “This funding will help maintain the Tri-Cities position at the cutting edge of scientific research and development,” said Senator Patty Murray. “I am pleased to support the work of Washington state scientific researchers as they work to develop new technologies to fight cancer.” Advanced Medical Isotope Corporation’s project will develop, test, and conduct research needed for FDA pre-market approval for a new polymer seed containing millions of tiny yttrium-90 microspheres. The seeds can be surgically implanted in tumors, just as radioactive metal seeds are placed in prostate and brain cancer patients. This treatment will provide an effective, highly localized and efficient method for treating against the more radiation-resistant brain tumors, pancreatic, head and neck tumors, and kidney tumors.